Ensign Peak Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.43M | Hold |
|
|||||
|
2025
Q1 | $4.29M | Hold |
|
|||||
|
2024
Q4 | $5.21M | Buy |
|
|||||
|
2024
Q3 | $1.1M | Hold |
|
|||||
|
2024
Q2 | $1.17M | Hold |
|
|||||
|
2024
Q1 | $913K | Hold |
|
|||||
|
2023
Q4 | $797K | Hold |
|
|||||
|
2023
Q3 | $607K | Hold |
|
|||||
|
2023
Q2 | $607K | Hold |
|
|||||
|
2023
Q1 | $1.05M | Hold |
|
|||||
|
2022
Q4 | $1.03M | Buy |
|
|||||
|
2022
Q3 | $241K | Buy |
|
|||||
|
2022
Q2 | $188K | Hold |
|
|||||
|
2022
Q1 | $304K | Hold |
|
|||||
|
2021
Q4 | $340K | Buy |
|
|||||
|
2021
Q3 | $45K | Sell |
|
|||||
|
2021
Q2 | $286K | Hold |
|
|||||
|
2021
Q1 | $386K | Hold |
|
|||||
|
2020
Q4 | $556K | Hold |
|
|||||
|
2020
Q3 | $618K | Buy |
|